NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,610 | -5.8% | 6,576 | -3.3% | 0.00% | 0.0% |
| Q2 2023 | $50,539 | -9.7% | 6,802 | -15.8% | 0.00% | 0.0% |
| Q1 2023 | $55,967 | -34.7% | 8,076 | -3.1% | 0.00% | -50.0% |
| Q4 2022 | $85,674 | -74.0% | 8,334 | -54.0% | 0.00% | -71.4% |
| Q3 2022 | $330,000 | -65.9% | 18,123 | -3.7% | 0.01% | -61.1% |
| Q2 2022 | $968,000 | -47.3% | 18,812 | -24.6% | 0.02% | -35.7% |
| Q1 2022 | $1,837,000 | -45.8% | 24,936 | +5.2% | 0.03% | -41.7% |
| Q4 2021 | $3,391,000 | -26.5% | 23,703 | +6.5% | 0.05% | -31.4% |
| Q3 2021 | $4,613,000 | -1.1% | 22,250 | +1.3% | 0.07% | +1.4% |
| Q2 2021 | $4,663,000 | +27.2% | 21,963 | +8.7% | 0.07% | +21.1% |
| Q1 2021 | $3,665,000 | +119.6% | 20,214 | +35.0% | 0.06% | +103.6% |
| Q4 2020 | $1,669,000 | +57.2% | 14,968 | +52.8% | 0.03% | +40.0% |
| Q3 2020 | $1,062,000 | +142.5% | 9,799 | +86.3% | 0.02% | +122.2% |
| Q2 2020 | $438,000 | – | 5,260 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |